Mangiferin and norathyriol acting on Alzheimer’s disease biomarkers: acetylcholinesterase, β-secretase (BACE-1), and amyloid β-peptide
We conclude that norathyriol is a promising prototype for drug development aimed at treating Alzheimer's disease.
Authors
- M. Trevisan (ORCID: https://orcid.org/0000-0003-1274-7497)
- Daniel Fábio Kawano (ORCID: https://orcid.org/0000-0002-4651-3472)
- Wanda P. Almeida (ORCID: https://orcid.org/0000-0002-7154-4668)
- Ana Cláudia Beneton Galeriani
- José Roberto Rodrigues de Souza (ORCID: https://orcid.org/0000-0003-3153-7014)
- Tiago Bento de Oliveira (ORCID: https://orcid.org/0000-0003-2862-4678)
Institutions
- Universidade Estadual de Campinas (UNICAMP) (BR)
- Universidade Federal do Ceará (BR)
- Instituto de Ciências Farmacêuticas (BR)
Publication Details
- Journal
- Journal of Pharmacy and Pharmacology
- Published
- 2025-07-04
- DOI
- https://doi.org/10.1093/jpp/rgaf055
- Primary Topic
- Mangiferin and Mango Extracts
- Type
- article
- Field-Weighted Citation Impact
- 0.00